Drug Profile
Research programme: anti-fungal vaccines - MiniVax
Alternative Names: MVX-504; MVX-507; PCP-VaccineLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Louisiana State University Health Sciences Center; MiniVax
- Developer MiniVax
- Class Fungal vaccines; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cryptococcosis; Pneumocystis pneumonia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pneumocystis pneumonia(Prevention) in USA (IM)
- 16 Jul 2016 No recent reports of development identified for research development in Cryptococcosis(Prevention) in USA (IM)
- 04 Jun 2012 Preclinical trials in Pneumocystis pneumonia (prevention) in USA (Injection)